Research Article
Impact of Body Mass Index on Short-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention in Newfoundland and Labrador, Canada
Table 6
Multivariate adjusted OR for nonvascular in-lab complications in patients undergoing PCI.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjusted for age, BMI, closure device, coumadin, diabetes, DVT, family history of premature CAD, GP IIb/IIIa inhibitors in-lab, gender, GI/liver disease, hypertension, IV heparin in-lab, LMWH in-lab, prior CABG, prior COPD, prior CVD, prior HF, prior PCI, prior PVD, pulmonary embolism, sheath size, and year. BMI: body mass index; CAD: coronary artery disease; CABG: coronary artery bypass grafting; COPD: chronic obstructive pulmonary disease; CVD: cardiovascular disease; DVT: deep vein thrombosis; GP: glycoprotein; HF: heart failure; LMWH: low molecular weight heparin; PCI: percutaneous coronary intervention; PVD: peripheral vascular disease. |